Research, published in the journal Ophthalmology, has reported that a post hoc analysis of data from the 36-month prospective, randomized FAME A and B Phase… Read More »Clinical research indicates beneficial effects of flucinolone acetonide implant on course of diabetic retinopathy.
Researchers investigating the genetic causes of familial exudative vitreoretinopathy (FEVR) in a Korean clinical study have found that patients with TSPAN12 large deletions appear to… Read More »Korean study shows that large gene deletions in TSPAN12 appear more common than single nucleotide variants in familial exudative vitreoretinopathy
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the January 21st, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA… Read More »January 21st, 2017: “EURETINA-Brief”© Issue No. 147
Research conducted by the International AMD Genomics Consortium (IAMDGC) has recently reported an almost doubling in the number of genetic risk loci associated with age-related… Read More »Findings from an international genomics consortium almost double the number of associated genetic loci and variants for AMD
GenSight Biologics Inc., (EURONEXT: SIGHT), Paris, France, have announced that their GS010 treatment for LHON provides sustained visual acuity 78 weeks after a dose escalating… Read More »GenSight Biologics Inc. reports sustained visual acuity 78 weeks after gene therapy treatment for Leber’s Hereditary Optic Neuropathy (LHON)
Research results reported by investigators based at the Department of Genetics & Microbiology, University of Barcelona, Spain, have shown that whole exome sequencing (WES) continues… Read More »Whole exome sequencing (WES) continues to yield significant efficiencies in clinical identification of inherited retinal degenerations.
Researchers studying the genetic basis of choroideremia have published results highlighting a clustering of lesions around 5 CpG sites within the CHM gene located on… Read More »Analysis of choroideremia gene (CHM) mutations highlight CpG mutation clusters and support gene replacement approaches
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the January 3rd, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA… Read More »January 3rd, 2017: “EURETINA-Brief”© Issue No. 146
Research conducted by the International AMD Genomics Consortium (IAMDGC) has recently reported an almost doubling in the number of genetic risk loci associated with age-related… Read More »Findings from an international genomics consortium almost double the number of associated genetic loci and variants for AMD
Stealth BioTherapeutics Inc., a biotechnology company based in Newtown, Massachusetts, have announced the initiation of a Phase I study in AMD to test the safety… Read More »Stealth BioTherapeutics intiates Phase I study with a novel compound targeting mitochondrial dysfunction in retinal disorders.